Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer

Cancer Letters(2024)10.1016/j.canlet.2024.216891Source: DataRank Database

Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer is a research paper published in Cancer Letters (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.66)OA: greenTopics (60)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Rangasudhagar Radhakrishnan ORCID,Revathy Nadhan ORCID,Rohini Gomathinayagam ORCID,Muralidharan Jayaraman ORCID,Mingda Yan

Live enrichment

PubMed:38642607 PMC:PMC12927523 OpenAlex:https://openalex.org/W4394936136

National Institute of General Medical Sciences

Grant: GM103639

National Cancer Institute

Grant: P30CA225520

US Department of Defense

Grant: W81XWH-18-1-0066

NIGMS NIH HHS

Grant: P20 GM103639

National Institutes of Health

FWCI

2.66

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12927523/

publisherhttps://api.elsevier.com/content/article/PII:S0304383524002842?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383524002842?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.canlet.2024.216891

Fields of Study

Cancer-related molecular mechanisms researchRNA Research and SplicingCancer, Lipids, and MetabolismFemaleHumansRNA, Long NoncodingOvarian NeoplasmsMicroRNAsAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmCell MovementXenograft Model Antitumor AssaysSignal TransductionMice, NudeLysophospholipidsMiceCisplatinReceptors, Lysophosphatidic Acid

MeSH Terms

AnimalsCell MovementCisplatinFemaleHumansLysophospholipidsMice, NudeOvarian NeoplasmsSignal TransductionGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmXenograft Model Antitumor AssaysMicroRNAsCell Line, TumorCell ProliferationReceptors, Lysophosphatidic AcidMiceRNA, Long Noncoding

Keywords

Ovarian cancerLysophosphatidic acidmicroRNACancer researchGene silencingCancerOvarian carcinomaBiologyTargeted therapySerous fluidMedicineInternal medicineGeneReceptorGpcrLncrnaTherapy ResistanceOncogenic PathwaysUca1Let-7 MirnasHigh Grade Serous Ovarian Carcinoma

Sustainable Development Goals

SDG 0: Good health and well-being

Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer

FAIR Checklist

Authors (14)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)